Working… Menu

MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma (MEDI2228)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03489525
Recruitment Status : Recruiting
First Posted : April 5, 2018
Last Update Posted : September 20, 2019
Information provided by (Responsible Party):
MedImmune LLC

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 23, 2021
Estimated Study Completion Date : April 23, 2021